XML 128 R62.htm IDEA: XBRL DOCUMENT v2.4.0.8
INTANGIBLE ASSETS AND GOODWILL (Details 2) (USD $)
3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Amortization and Impairments of Finite-lived Intangible Assets
Developed Markets
Non-recurring basis
Ezogabine Retigabine
Sep. 30, 2013
Amortization and Impairments of Finite-lived Intangible Assets
Developed Markets
Non-recurring basis
Discontinued OTC Skincare [Member]
Mar. 31, 2013
Amortization and Impairments of Finite-lived Intangible Assets
Developed Markets
Non-recurring basis
Opana
Sep. 30, 2013
In-process Research and Development Impairments and Other Charges
Developed Markets
Non-recurring basis
Ezogabine Retigabine
Sep. 30, 2013
U.S
Amortization and Impairments of Finite-lived Intangible Assets
Developed Markets
Non-recurring basis
Discontinued OTC Skincare [Member]
Sep. 30, 2013
Australia
Amortization and Impairments of Finite-lived Intangible Assets
Developed Markets
Non-recurring basis
Discontinued OTC Skincare [Member]
Sep. 30, 2013
Brazilian, Canadian, and Polish Markets [Member]
Amortization and Impairments of Finite-lived Intangible Assets
Developed Markets
Non-recurring basis
Discontinued OTC Skincare [Member]
Sep. 30, 2013
Brazilian, Canadian, and Polish Markets [Member]
Amortization and Impairments of Finite-lived Intangible Assets
Developed Markets
Non-recurring basis
Opana
Sep. 30, 2013
In Process Research and Development [Member]
In-process Research and Development Impairments and Other Charges
Non-recurring basis
Ezogabine Retigabine
Sep. 30, 2013
In Process Research and Development [Member]
In-process Research and Development Impairments and Other Charges
Non-recurring basis
Lacrisert
Intangible assets                            
Impairment charges on intangible assets         $ 551,600,000 $ 10,000,000 $ 22,200,000 $ 93,800,000 $ 10,000,000 $ 31,500,000 $ 22,300,000 $ 22,200,000 $ 93,800,000 $ 27,300,000
Amortization expense related to intangible assets recorded as follows:                            
Cost of goods sold 0 0 0 2,557,000                    
Amortization and impairments of finite-lived intangible assets (see Note 10) 910,248,000 218,187,000 1,540,021,000 629,400,000                    
Total amortization of intangible assets 910,248,000 218,187,000 1,540,021,000 631,957,000                    
Estimated aggregate amortization expense                            
2013 1,243,488,000 [1]   1,243,488,000 [1]                      
2014 1,365,817,000 [1]   1,365,817,000 [1]                      
2015 1,317,121,000 [1]   1,317,121,000 [1]                      
2016 1,230,973,000 [1]   1,230,973,000 [1]                      
2017 $ 1,177,238,000 [1]   $ 1,177,238,000 [1]                      
[1] Amortization expense shown in the table above does not include impairments of finite-lived intangible assets.